Come up with a name for your new list and we'll add to it:
Cynvenio Biosystems raised a round of funding on February 07, 2012. Investors include
National Cancer Institute.
Cynvenio Biosystems, formerly CytomX, is focused on the development of the LiquidBiopsy platform, a high performance rare cell isolation technology for biomedical research and cancer diagnostics. Liqu…